Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (271-280 of 331) with videos related to

Pageof 34
Sort By:
JAMA|January 3, 2013
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trialsSana M Al-Khatib, Anne Hellkamp, Gust H Bardy, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
JACC. Heart Failure|December 30, 2014
Primary prevention implantable cardioverter-defibrillators and survival in older womenEmily P Zeitler, Anne S Hellkamp, Gregg C Fonarow, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Journal of the American College of Cardiology|December 20, 2005
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questionsJeroen J Bax, Theodore Abraham, S Serge Barold, et al.
Journal of the American College of Cardiology|August 9, 2008
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Joseph A Blatt, Jeanne E Poole, George W Johnson, et al.
Journal of the American College of Cardiology|December 20, 2005
Cardiac resynchronization therapy: Part 1--issues before device implantationJeroen J Bax, Theodore Abraham, S Serge Barold, et al.
American Heart Journal|May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensusShelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.
American Heart Journal|August 10, 2016
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trialPadma Kaul, E Magnus Ohman, J David Knight, et al.
American Heart Journal|May 22, 2025
Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trialHarvey D White, Sean M O'Brien, William E Boden, et al.
Pageof 34

Showing results (271-280 of 331) with videos related to

Sort By:
Pageof 34
JAMA|January 3, 2013
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trialsSana M Al-Khatib, Anne Hellkamp, Gust H Bardy, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
JACC. Heart Failure|December 30, 2014
Primary prevention implantable cardioverter-defibrillators and survival in older womenEmily P Zeitler, Anne S Hellkamp, Gregg C Fonarow, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Journal of the American College of Cardiology|December 20, 2005
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questionsJeroen J Bax, Theodore Abraham, S Serge Barold, et al.
Journal of the American College of Cardiology|August 9, 2008
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Joseph A Blatt, Jeanne E Poole, George W Johnson, et al.
Journal of the American College of Cardiology|December 20, 2005
Cardiac resynchronization therapy: Part 1--issues before device implantationJeroen J Bax, Theodore Abraham, S Serge Barold, et al.
American Heart Journal|May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensusShelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.
American Heart Journal|August 10, 2016
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trialPadma Kaul, E Magnus Ohman, J David Knight, et al.
American Heart Journal|May 22, 2025
Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trialHarvey D White, Sean M O'Brien, William E Boden, et al.
Pageof 34